This organisation, with members from the public and private sector, aims to promote patient safety and raise awareness about the problem of counterfeit medicines. The website offers advice on detecting counterfeit medicines in the local pharmacy or online — by noticing whether a tablet has an unusual smell or taste, for example. It also provides an overview of counterfeit medicines, features relevant news stories and outlines the technological tools that manufacturers or pharmacists can use to detect fake drugs.

This global coalition of stakeholders — international and nongovernmental organizations, drug manufacturers and regulatory authorities —was set up by the WHO and works globally to tackle the production, trade and sale of counterfeit medical products. The website publishes information about the organisation’s activities and five working groups of experts that focus on specific aspects of the problem. It also provides a list of resources, including recommendations on raising awareness about the issue.  Through IMPACT, the WHO has developed guidelines for measures to combat counterfeit medicines, which are also available on the website.

This group of mainly not-for-profit organisations works to protect consumers from counterfeit medicines. The website publishes an encyclopaedia of counterfeit drug incidents documenting details of where, when and how counterfeit drugs or other medical products have been identified in the legitimate drug supply around the world. Press releases, news articles, resources on online pharmacy regulations and contact details of experts in the field are free to access. The site also features relevant research articles and includes a guide advising pharmacists on how to be alert to counterfeit medicines.

The PSI is a network of 25 pharmaceutical companies set up to improve information sharing about counterfeit pharmaceuticals. The website provides an overview of definitions, trends and detections of counterfeit drugs, and provides links to useful resources — such as trusted online suppliers of medicine and guides to detecting fake drugs. The institute informs law-enforcement and regulatory agencies when it receives information about organisations or individuals that could be involved in counterfeiting. It focuses on ending drug manufacturers' commercial losses through counterfeiting — generally those bigger than US$100,000 or activities involving large criminal networks.